Biomemory Launches DNA Shield, First Commercial Product Built on Its Molecular IT Platform
The launch follows the acquisition of catalog's assets and the appointment of Laurent Guengant as CEO earlier this year.
Summary from Dark Reading.
The launch follows the acquisition of catalog's assets and the appointment of Laurent Guengant as CEO earlier this year.
Summary from Dark Reading.